KARO PHARMA AS

0661 OSLO

Finances

Share Ownership

Return on Equity

66,38 %

Current Ratio

1,45

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	641 458 000	529 516 000	425 492 000	443 050 000
Net Income	98 432 000	109 151 000	83 972 000	57 775 000
Total Assets	381 062 000	378 532 000	282 382 000	301 262 000
Total Equity	148 287 000	152 743 000	131 169 000	132 577 000

Income (NOK)	2022	2021	2020	2019
Revenue	641 458 000	529 516 000	425 492 000	443 050 000
Expenditure	511 482 000	385 757 000	313 079 000	369 370 000
Operating Profit	129 975 000	143 759 000	112 413 000	73 680 000
Financial Income	5 481 000	1 075 000	404 000	1 744 000
Financial Costs	9 255 000	4 893 000	5 113 000	1 297 000
Financial Balance	−3 774 000	−3 818 000	−4 709 000	447 000
Earnings Before Tax	126 201 000	139 942 000	107 704 000	74 127 000
Tax	27 769 000	30 791 000	23 732 000	16 352 000
Net Income	98 432 000	109 151 000	83 972 000	57 775 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	42 714 000	46 604 000	56 779 000	61 318 000
Total Current Assets	338 348 000	331 928 000	225 603 000	239 944 000
Total Assets	381 062 000	378 532 000	282 382 000	301 262 000
Total Retained Equity	139 788 000	144 244 000	124 371 000	125 779 000
Total Equity	148 287 000	152 743 000	131 169 000	132 577 000
Total Long-Term Debt	0	2 864 000	2 642 000	2 561 000
Total Current Debt	232 775 000	222 926 000	148 571 000	166 124 000
Total Equity and Debt	381 062 000	378 532 000	282 382 000	301 262 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	640 717 000	504 255 000	406 907 000	443 050 000
Other Income	741 000	25 260 000	18 585 000	0
Revenue	641 458 000	529 516 000	425 492 000	443 050 000
Cost of Goods Sold	296 008 000	211 576 000	182 064 000	218 126 000
Salary Costs	30 968 000	29 910 000	31 614 000	28 616 000
Depreciation	4 055 000	4 086 000	4 388 000	4 708 000
Impairment	2 042 000	0	498 000	29 779 000
Expenditure	511 482 000	385 757 000	313 079 000	369 370 000
Operating Profit	129 975 000	143 759 000	112 413 000	73 680 000
Financial Income	5 481 000	1 075 000	404 000	1 744 000
Financial Costs	9 255 000	4 893 000	5 113 000	1 297 000
Financial Balance	−3 774 000	−3 818 000	−4 709 000	447 000
Dividends	0	0	0	0
Net Income	98 432 000	109 151 000	83 972 000	57 775 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	15 537 000	0
Total Intangible Assets	39 802 000	44 232 000	53 959 000	57 575 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	2 911 000	2 372 000	2 820 000	3 743 000
Total Tangible Assets	2 911 000	2 372 000	2 820 000	3 743 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	42 714 000	46 604 000	56 779 000	61 318 000
Stock	18 261 000	106 562 000	80 614 000	61 248 000
Total Investments	0	0	0	0
Cash, Bank	1 035 000	2 348 000	10 710 000	74 576 000
Total Current Assets	338 348 000	331 928 000	225 603 000	239 944 000
Total Assets	381 062 000	378 532 000	282 382 000	301 262 000
Total Equity	148 287 000	152 743 000	131 169 000	132 577 000
Short-Term Group Debt	139 046 000	154 728 000	70 910 000	80 200 000
Total Long-Term Debt	0	2 864 000	2 642 000	2 561 000
Creditors	40 917 000	33 032 000	28 306 000	41 016 000
Unpaid Taxes	23 376 000	16 874 000	14 098 000	15 286 000
Dividends	0	0	0	0
Other Current Debt	29 436 000	18 292 000	35 257 000	29 622 000
Total Current Debt	232 775 000	222 926 000	148 571 000	166 124 000
Total Equity and Debt	381 062 000	378 532 000	282 382 000	301 262 000

Financial indicators	2022	2021	2020	2019
Return on Equity	66,38 %	71,46 %	64,02 %	43,58 %
Debt-to-Equity Ratio	0	0,02	0,02	0,02
Operating Profit Margin	20,26 %	27,15 %	26,42 %	16,63 %
Current Ratio	1,45	1,49	1,52	1,44
Quick Ratio	1,58	2,85	3,32	2,29
Equity Ratio	0,39	0,4	0,46	0,44
Gross Profit Margin	53,85 %	60,04 %	57,21 %	50,77 %